1. Home
  2. OPAD vs VNRX Comparison

OPAD vs VNRX Comparison

Compare OPAD & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

OPAD

Offerpad Solutions Inc.

N/A

Current Price

$4.25

Market Cap

24.5M

Sector

Finance

ML Signal

N/A

Logo VolitionRX Limited

VNRX

VolitionRX Limited

N/A

Current Price

$0.38

Market Cap

24.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OPAD
VNRX
Founded
2015
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.5M
24.5M
IPO Year
2020
2012

Fundamental Metrics

Financial Performance
Metric
OPAD
VNRX
Price
$4.25
$0.38
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$1.83
$1.67
AVG Volume (30 Days)
52.7K
8.8M
Earning Date
04-30-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
33.92
38.00
EPS
N/A
N/A
Revenue
$567,812,000.00
$1,727,384.00
Revenue This Year
N/A
$355.66
Revenue Next Year
$32.08
$849.08
P/E Ratio
N/A
N/A
Revenue Growth
N/A
40.04
52 Week Low
$0.54
$0.13
52 Week High
$6.09
$3.26

Technical Indicators

Market Signals
Indicator
OPAD
VNRX
Relative Strength Index (RSI) 50.76 30.81
Support Level $4.15 $0.18
Resistance Level $4.62 $0.39
Average True Range (ATR) 0.30 0.07
MACD -0.00 0.02
Stochastic Oscillator 60.71 13.28

Price Performance

Historical Comparison
OPAD
VNRX

About OPAD Offerpad Solutions Inc.

Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services, including mortgage, listing, renovation, and buyer representation services.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.

Share on Social Networks: